SBFMW Market Analysis
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-2.210.0% YoY
Profit margin-16.5%
Market cap—
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -21.9%
- Operating margin
- -17.4%
- Revenue growth YoY
- -1.6%
- Dividend yield
- —
- Beta
- 1.32
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Sunshine Biopharma Inc. Warrant
Company profileSunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is headquartered in Pointe-Claire, Canada.
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 333 LAS OLAS WAY, FORT LAUDERDALE, FL
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Shares outstanding$0
52W high$0.42
52W low$0.02
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent